curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page

Study of Deucravacitinib for Refractory Adults With Dermatomyositis/Juvenile Dermatomyositis

by palligoelme@gmail.com | Jun 11, 2025 | Clinical Trials

​ Conditions: Myositis; Dermatomyositis Interventions: Drug: Deucravacitinb Sponsors: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Not yet recruiting Conditions: Myositis; Dermatomyositis Interventions: Drug: Deucravacitinb Sponsors:...

Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment

by palligoelme@gmail.com | Jun 11, 2025 | Clinical Trials

​ Conditions: Keratinocyte Carcinoma; Basal Cell Carcinomas; Squamous Cell Carcinoma; Skin Cancer Interventions: Drug: Tirbanibulin ointment 1%; Device: non-ablative fractional laser Sponsors: Bruce Robinson, MD Recruiting Conditions: Keratinocyte Carcinoma; Basal...

ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis

by palligoelme@gmail.com | Jun 10, 2025 | Clinical Trials

​ Conditions: Atopic Dermatitis; Atopic; Dermatitis; AD; Eczema Interventions: Drug: ATI-045; Drug: Placebo Sponsors: Aclaris Therapeutics, Inc. Recruiting Conditions: Atopic Dermatitis; Atopic; Dermatitis; AD; Eczema Interventions: Drug: ATI-045; Drug: Placebo...

Muscle Injury RTP Design in Football; Effects of Backward Design vs Forward Design: A Randomized Controlled Trial

by palligoelme@gmail.com | Jun 10, 2025 | Clinical Trials

​ Conditions: Muscle Injuries; Football Players Interventions: Other: Return to play program with progressive design; Other: Return to play program with regressive design Sponsors: Universitat de les Illes Balears Not yet recruiting Conditions: Muscle Injuries;...

Staphylococcus Haemolyticus in the Neonatal Intensive Care Unit of CHSD in 2023: Analysis and Trends

by palligoelme@gmail.com | Jun 10, 2025 | Clinical Trials

​ Conditions: Staphylococcus Haemolyticus; Staphylococcal Infections; Sepsis; Catheter-Related Infections; Infant, Newborn; Intensive Care Units, Neonatal; Cross Infection; Drug Resistance, Bacterial Sponsors: Centre Hospitalier de Saint-Denis Completed Conditions:...

Study of BPN14770 in Participants With Severe Renal Impairment and Healthy Controls

by palligoelme@gmail.com | Jun 10, 2025 | Clinical Trials

​ Conditions: Renal Impairment Interventions: Drug: BPN14770 Sponsors: Shionogi Not yet recruiting Conditions: Renal Impairment Interventions: Drug: BPN14770 Sponsors: Shionogi Not yet recruiting 
« Older Entries
Next Entries »

Recent Posts

  • Using Mirabegron to Control Arrhythmia-1
  • Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD)
  • Cluster Non-RCT on Pulsatile Flushing Technique in Reducing Blockage of T-CVAD for Haemodialysis Patients
  • The Role of Platelet-rich Plasma Local Injection as Treatment in Improvement of Pilonidal Sinus Surgery Outcomes
  • Stage IV Lung Squamous Cell Carcinoma Treated With or Without Bronchial Artery Chemoembolization After First-line Chemotherapy and Immunotherapy

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®